Free Trial
NASDAQ:NEOG

Neogen (NEOG) Stock Price, News & Analysis

$14.46
-0.15 (-1.03%)
(As of 10/17/2024 ET)

About Neogen Stock (NASDAQ:NEOG)

Key Stats

Today's Range
$14.34
$14.82
50-Day Range
$13.79
$17.53
52-Week Range
$11.46
$20.89
Volume
945,959 shs
Average Volume
1.96 million shs
Market Capitalization
$3.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.50
Consensus Rating
Hold

Company Overview

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Neogen Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
47th Percentile Overall Score

NEOG MarketRank™: 

Neogen scored higher than 47% of companies evaluated by MarketBeat, and ranked 759th out of 1,012 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Neogen has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Neogen has only been the subject of 1 research reports in the past 90 days.

  • Read more about Neogen's stock forecast and price target.
  • Earnings Growth

    Earnings for Neogen are expected to grow by 18.52% in the coming year, from $0.54 to $0.64 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Neogen is -361.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Neogen is -361.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Neogen has a P/B Ratio of 1.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Neogen's valuation and earnings.
  • Percentage of Shares Shorted

    10.60% of the outstanding shares of Neogen have been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 14.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Neogen has recently increased by 4.08%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Neogen does not currently pay a dividend.

  • Dividend Growth

    Neogen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.60% of the outstanding shares of Neogen have been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 14.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Neogen has recently increased by 4.08%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Neogen has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for Neogen this week, compared to 5 articles on an average week.
  • Search Interest

    5 people have searched for NEOG on MarketBeat in the last 30 days.
  • MarketBeat Follows

    3 people have added Neogen to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Neogen insiders have bought more of their company's stock than they have sold. Specifically, they have bought $250,680.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.71% of the stock of Neogen is held by insiders.

  • Percentage Held by Institutions

    96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Neogen's insider trading history.
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Stock News Headlines

Neogen (NASDAQ:NEOG) Shares Gap Up on Insider Buying Activity
[Urgent] Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.
Piper Sandler Sticks to Their Hold Rating for Neogen (NEOG)
Neogen Corporation (NEOG)
See More Headlines

NEOG Stock Analysis - Frequently Asked Questions

Neogen's stock was trading at $20.11 at the beginning of the year. Since then, NEOG stock has decreased by 28.1% and is now trading at $14.46.
View the best growth stocks for 2024 here
.

Neogen Co. (NASDAQ:NEOG) announced its quarterly earnings results on Thursday, October, 10th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by $0.03. The business's revenue for the quarter was down 5.2% on a year-over-year basis.

Shares of Neogen split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were payable to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

Neogen's top institutional shareholders include McCollum Christoferson Group LLC (0.12%), IQ EQ FUND MANAGEMENT IRELAND Ltd (0.07%), Diversified Trust Co (0.03%) and Carnegie Investment Counsel (0.03%). Insiders that own company stock include John Edward Adent, Douglas Edward Jones, Steven J Quinlan, David H Naemura, Jason Warren Lilly, William T Boehm, James P Tobin, James C Borel, Ronald D Green and Darci L Vetter.
View institutional ownership trends
.

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neogen investors own include NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
10/10/2024
Today
10/17/2024
Next Earnings (Estimated)
1/14/2025
Fiscal Year End
5/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
2,640
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$17.50
High Stock Price Target
$17.50
Low Stock Price Target
$17.50
Potential Upside/Downside
+21.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-9,420,000.00
Pretax Margin
-1.55%

Debt

Sales & Book Value

Annual Sales
$912.20 million
Cash Flow
$1.00 per share
Book Value
$14.52 per share

Miscellaneous

Free Float
214,249,000
Market Cap
$3.13 billion
Optionable
Optionable
Beta
1.21

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NASDAQ:NEOG) was last updated on 10/17/2024 by MarketBeat.com Staff
From Our Partners